Physician profile
Rocelious Goodson
NPI 1992863872
$1,931.51
in general payments reported to CMS, 2019-2025
11 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what 83% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $276 · 2023: $258 · 2024: $236 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,655.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $749.86 | 2024-2025 | Endurant Iis |
| W. L. Gore & Associates, INC. | $318.29 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Propaten Vascular Graft Pediatric Shunt |
| Ethicon US, LLC | $195.38 | 2022-2025 | Surgicel Nu-Knit, Stratafix, Dermabond |
| Imperative Care, INC | $181.30 | 2025 | Prodigy Catheter |
| Lundbeck LLC | $110.20 | 2025 | Rexulti |
| Penumbra, INC. | $98.21 | 2025 | Indigo System |
| Integra Lifesciences Corporation | $73.26 | 2022 | |
| Janssen Scientific Affairs, LLC | $69.01 | 2022 | |
| Shockwave Medical, INC | $62.64 | 2022 | |
| Boston Scientific Corporation | $39.27 | 2024 | |
| Alkermes, INC. | $34.09 | 2025 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rocelious Goodson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.